Over the past few months, more than 80 000 Americans with COVID-19 have been treated
with convalescent plasma, under an expanded access programme. The programme was …

Background Many patients with COVID-19 have been treated with plasma containing anti-
SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent …

❚ ABSTRACT The objective of this study was to highlight the global scientific effort to fight
the SARS-CoV-2, addressing the preliminary results of passive immunization through …

Convalescent plasma therapy has shown controversial results in coronavirus disease-19
(COVID-19) patients. We performed a non-randomized case-control study with …

abstract Background: Randomized trials are generally performed from a frequentist
perspective, which can conflate absence of evidence with evidence of absence. The …

Abstract John S. Daniels, MD Retiring Internal Medicine Missouri Medicine Editorial Board
Member, St. Louis Use of Convalescent Plasma in the Management of COVID-19 The …

In this issue of the Saudi Journal of Medicine and Medical Sciences, AlShehry et al. report
the interim findings of a phase II trial that describes the outcomes of 40 hospitalized adults …

Background: There are currently no proven treatment options for Coronavirus Disease 2019
(COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) …

Background Treatment of COVID-19 patients with plasma containing anti-SARS-CoV-2
antibodies may have a beneficial effect on clinical outcomes. We aimed to evaluate the …

On December 7 th, WHO updated its living guideline on COVID-19 therapeutics, including
convalescent plasma (CCP). This led to their recommendation against the use of CCP for …